P
Philip Rubin
Researcher at University of Rochester Medical Center
Publications - 139
Citations - 9596
Philip Rubin is an academic researcher from University of Rochester Medical Center. The author has contributed to research in topics: Radiation therapy & Survival rate. The author has an hindex of 45, co-authored 139 publications receiving 9278 citations. Previous affiliations of Philip Rubin include University of Rochester.
Papers
More filters
Journal ArticleDOI
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.
Andy Trotti,A. Dimitrios Colevas,Ann Setser,Valerie W. Rusch,David P. Jaques,Volker Budach,Corey J. Langer,Barbara A. Murphy,Richard Cumberlin,C. Norman Coleman,Philip Rubin +10 more
TL;DR: Recent progress in the evolution of adverse effects grading systems is updated and the development of CTCAE v3.0 is reviewed, which represents an international collaboration and consensus of the oncology research community.
Journal ArticleDOI
Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group
Carlos A. Perez,Thomas F. Pajak,Philip Rubin,Joseph R. Simpson,Mohammed Mohiuddin,Luther W. Brady,R. Perez-Tamayo,Marvin Rotman +7 more
TL;DR: The high frequency of brain metastases suggests that, as in small cell carcinoma of the lung, elective irradiation of the brain may be necessary, if not to improve survival to enhance the quality of life of patients with adenocarcinoma and large cell carcinomas.
Journal ArticleDOI
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group
Miljenko V. Pilepich,William T. Sause,William U. Shipley,John M. Krall,Colleen A. Lawton,David J. Grignon,Muhyi Al-Sarraf,Ross A. Abrams,Richard J. Caplan,Madhu John,Marvin Rotman,James D. Cox,R.L. Scotte Doggett,Philip Rubin,Mark S. Soloway +14 more
TL;DR: Short-term androgen deprivation with radiation therapy results in a marked increase in local control and disease-free survival compared with pelvic irradiation alone in patients with locally advanced carcinoma of the prostate.
Journal ArticleDOI
A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group
Carlos A. Perez,K. Stanley,Philip Rubin,Simon Kramer,L. Brady,R. Perez-Tamayo,G. S. Brown,Joseph P. Concannon,M. Rotman,H.G. Seydel +9 more
TL;DR: The data strongly suggest that patients treated with 5000 or 6000 rad have a better response, tumor control, and survival rate than those receiving lower doses, however, additional followup of patients at risk in each group will be necessary before a final conclusion is drawn.
Journal ArticleDOI
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
Colleen A. Lawton,Minhee Won,Miljenko V. Pilepich,Sucha O. Asbell,William U. Shipley,Gerald E. Hanks,James D. Cox,Carlos A. Perez,William T. Sause,S. Doggett,Philip Rubin +10 more
TL;DR: These data from two large multi-institutional trials represent a fair estimate of the actual incidence of major intestinal and urinary complications from external beam irradiation in the management of local and locoregional adenocarcinoma of the prostate.